Marketresearchnews

Monday, 3 February 2020

Laser Probe Market Growth and Restrain Factors Analysis By 2023

Market Analysis

The global laser probe market is predicted to touch USD 1560.76 million at a 9.11% CAGR between 2018-2023, reveals the latest Market Research Future (MRFR) report. Laser probe, simply put, is an ophthalmic medical device that has been designed for various diagnostic applications. This diagnostic procedure is minimally-invasive, where the laser probes aid in detecting the abnormalities, if any, in the brain, eye, and other areas. The laser probe assists in the real-time determination of abnormalities instead of extracting samples from patients and conducting different diagnostic procedures on it. It leads to better efficiency of treatment as well as reduced time taken for determining the outcomes of the procedure.

Various factors are propelling the laser probe market growth. These factors, as stated by the latest Market Research Future (MRFR) report, include rising prevalence of cases where laser probes are needed, increasing incidence of ophthalmic disorders/diseases owing to growing number of diabetic patients, growing geriatric population, increasing incidence of medical emergencies, and increasing number of glaucoma and cataract surgeries. Additional factors pushing market growth include rising prevalence of chronic diseases, especially prostate cancer, barrette’s esophagus, non-melanoma skin cancer, and diabetic retinopathy, among others, technological innovations and improvements in reimbursement protocols.

On the flip side, the availability of alternative devices and technologies in the market and absence of technically skilled experts to use such devices are factors that may impede the laser probe market growth over the forecast period.

Market Segmentation

The Market Research Future report provides an all-inclusive segmental analysis of the laser probe market trends, growth and study on the basis of end user, application, product type, and probe type.

Based on product type, the laser probe market is segmented into continuous-wave laser probes, pulsed laser probes, and others. Of these, the continuous-wave laser probes segment will have the largest share in the market over the forecast period. It is widely used in different dermatological procedures, including marks or scars removal, and wrinkle reduction.

Based on the probe type, the laser probe market is segmented into a single laser probe, cluster laser probe, and others. Of these, the single laser probe segment will dominate the market over the forecast period.

Based on the application, the laser probe market is segmented into rheumatology, dentistry, ophthalmology, orthopedics, dermatology, and others. Of these, the ophthalmology segment will lead the market over the forecast period, followed by the dermatology segment.

Based on the end user, the laser probe market is segmented into tertiary hospitals, clinics, and others. Of these, the tertiary hospitals segment will have the maximum share in the market over the forecast period owing to the rapid proliferation of tertiary hospitals both in suburban and urban areas.

Regional Analysis

By region, the laser probe market report covers the latest trends and growth opportunities across the Americas, the Middle East and Africa, Europe, and the Asia Pacific. Of these, the Americas will remain the driving force in the market during the forecast period chiefly on account of the burgeoning demand for minimally invasive cosmetic surgeries, arthritis treatment, and cataract procedures. This will be followed by Europe, which is predicted to have the second-largest share in the market over the forecast period.

Key Players

Major players profiled in the laser probe market report include Quantel Medica, Iridex Corporation, Vitreq, OphthalMed LLC, Lumenis, Transonic Systems Inc., ADInstruments, Reimers & Janssen GmbH, Omega Laser Systems Limited, FCI, Bausch & Lomb Incorporated, and Alcon (Novartis). Key players have used multiple strategies to create a foothold in the market, such as expansions, partnerships, acquisitions, and more.

Industrial News

March 2019: Researchers in Canada have created a laser probe that utilizes changes in light patterns for detecting melanoma, one of the deadliest skin cancers. The researchers claimed that this laser probe could offer a numerical result that is easily understandable akin to the principal of a thermometer. Irrespective of its usability and low cost, this device is a clinical tool to diagnose melanoma instead of being a consumer product.

Browse More Medical Devices Reports @ https://www.marketresearchfuture.com/categories/medical-devices-market-report

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Duodenal Cancer Market 2019 Share, Trend, Segmentation and Forecast to 2023

Market Overview

The worldwide duodenal cancer market is anticipated to develop gradually over the forecast period. The global duodenal cancer market is estimated to record a CAGR of 3.2% over the forecast period of 2018–2023.

It is a rare kind of cancer that develops in the uppermost part of the small intestine. As the cancer cells start generating in the duodenum, it develops tumors. The tumors block food from passing through the digestive tract. At this point, the body or the small intestine is unable to extract the essential vitamins. The patient experiences a number of symptoms.

Symptoms can be ambiguous, which makes early diagnosis difficult. Duodenum plays a significant role in the digestive system. Bile and chemical secretions are passed through duodenum which helps the food to break down. Duodenal cancer disrupts the digestive process and prevents the body from absorbing essential minerals. Several diagnoses have managed to detect it at an early stage. Tests that capture detailed images of the GI tract, such as a CT scan or MRI, tests such as endoscopy, that examines the inner surface of the GI tract with the help of a flexible pipe with an attached small camera or the technique widely known as biopsy where a part of tissue is eliminated for analysis, could help the patient with the early detection of the disease.

Rising prevalence of chronic ailments, increasing instances of rare cancers, increasing geriatric population, and technological advancements are projected to stimulate the market growth. In January 2018, for instance, GE Healthcare entered into a long-term partnership with Roche Diagnostics to co-create and promote digital medical decision support services. With this, the firms will primarily focus on solutions that improve and accelerate personalized treatment options for critical care patients.

Furthermore, increased healthcare investment is likely to influence the worldwide duodenal cancer market size. However, strict administrative regulations for product approval and expensive treatments are major factors undermining the market potential.

Market Segmentation

The worldwide duodenal cancer market has been segmented based on treatment, diagnosis, and type.

Based on treatment, the market has been segmented into chemotherapy, radiotherapy, and surgery.

Based on diagnosis, the market has been segmented into capsule endoscopy, colonoscopy or endoscopy, MRI scan, CT scan, barium X-ray, and other tests.

Based on type, the global duodenal market has been segmented into sarcoma, adenocarcinoma, lymphoma, and neuroendocrine (carcinoid) tumors.

Regional Analysis

The Americas lead the worldwide duodenal cancer market owing to factors such as high healthcare expenditure, growing incidences of chronic & rare ailments, and access to well-established healthcare system. The American Society of Clinical Oncology (ASCO) recorded in January 2018 that 60% of the population had been diagnosed with duodenal cancer at the distant or initial phase. Europe holds the second-largest market share on account of the healthcare supports provided by the government coupled with the occurrences of several chronic ailments. The Asia-Pacific market is likely to be driven by factors such as surge in disposable income, government funding for healthcare units and growing prevalence of chronic diseases. MEA accounts for the smallest share of the global duodenal cancer market. The market growth in this region can be attributed to the improving healthcare set-up and increasing investment in the healthcare sector.

Key Players

The key players in the worldwide duodenal cancer market includes Pfizer Inc., Eli Lilly & Company, Bristol-Myers Squibb Company, AbbVie, Inc., F. Hoffman-La Roche Ltd., Novartis AG, Thermo Fisher Scientific, Bayer AG, Boehringer Ingelheim International GmbH, Ipsen Biopharmaceuticals Inc., Abbott, G E Healthcare, AstraZeneca, Agilent Technologies Inc., Dickinson & Company, and Becton.

Browse More Pharmaceutical Reports @ https://www.marketresearchfuture.com/categories/pharmaceutical-market-report

About US:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Bone Implant Market Trends and Drivers Analysis 2019 To 2023

Americas to Dominate Bone Implant Market due to High Availability of Advanced Technology

The global bone implant market share is expected to rise at a CAGR of 6.8% over the forecast period from 2018 to 2023, according to the latest research report from Market Research Future (MRFR). The global bone implant market is mainly driven by the growing technological advancement in bone implants, which has led to the availability of a number of viable options in the bone implants market, and the growing need for bone implant procedures around the world. The rising prevalence of sports injuries and other bone injuries is also likely to be a major driver for the global bone implant market over the forecast period.

Rapid advancement of the technology around bone implants is likely to be a major driver for the global bone implant market over the forecast period. With time, the global bone implants market has grown rapidly, leading to steady development of a number of products that can be viably used as bone implants. The steady development of the materials industry has also led to a rapid rise for the global bone implants market, as a number of viable materials have been developed that can be used to produce effective bone implants. This is likely to remain a major driver for the global bone implants market over the forecast period, as the material plays a key part in ensuring long-term viability of the bone implant. Materials such as ceramics and polymers are likely to undergo extensive research in the coming years, leading to steady growth of the bone implant market.

On the other hand, the high prices of orthopedic surgeries and bone implant products could hinder the global bone implant market’s growth over the forecast period. Government policies could also hinder the use of specific products in the global bone implant market over the forecast period.

Competitive Analysis:

Leading players in the global bone implant market include Depuy Synthes Inc., NuVasive Inc., Stryker Corporation, Integra LifeSciences Holdings Corporation, The Orthopedic Implant Company, Aesculap Implant Systems, Conmed Corporation, Arthrocare Corporation, BioTek Instruments Inc., Wright Medical Group N.V., Medtronic plc, Zimmer Biomet Holdings Inc., Smith & Nephew plc, and Globus Medical Inc.

Acquisitions and mergers and likely to remain a popular tactic for players in the global bone implant market over the forecast period.

In May 2018, NN Inc. acquired Paragon Medical for USD 375 million.

In 2017, Stryker Corporation acquired Vexim for USD 215 million.

Segmentation:

The global bone implant market has been segmented on the basis of biomaterial, product, application, device, end user, and region.

On the basis of biomaterial, the bone implant market has been classified as metals, ceramics, and polymers. The metal segment has been further divided into titanium, stainless steel, cobalt chromium alloy, gold alloys, and tantalum. The ceramics segment has been further divided into alumina, hydroxyapatite, beta-tricalcium, phosphate, carbon, bioglass, zirconia, and zirconia-toughened alumina. The polymers segment has been sub-segmented into polymethylmethacrylate, polytetrafluoroethylene, polyethylene, polysulfone, polyurethane, and polyether ether ketone.

By product, the market is segmented into orthopedic screws, orthopedic plates, interlocking nails (rods), and others.

By application, the bone implant market is segmented into hip orthopedic implants, knee orthopedic implants, spine orthopedic implants, dental orthopedic implants, and others.

By device, the market is segmented into external fixators and internal fixators.

By end user, the market is segmented into orthopedic clinics, hospitals, and others.

Regional Analysis:

The Americas is likely to remain the major regional party in the global bone implant market over the forecast period. The advanced healthcare sector in the region, the high disposable income of consumers in developed countries such as the U.S. and Canada, and the growing prevalence of sports injuries in the region are likely to drive the bone implant market in the Americas region over the forecast period.

The rising prevalence of orthopedic diseases in Europe is likely to drive the regional market for bone implants over the forecast period. Asia Pacific is also likely to exhibit a rapid growth in the bone implant market over the forecast period due to the growing prevalence of orthopedic conditions.

Browse more Medical Devices Reports @ https://www.marketresearchfuture.com/categories/medical-devices-market-report

About US:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Acoustic Neuroma Market Therapeutics in Global Markets to 2023 - Growth Driven by Increasing Uptake of Targeted Therapies and Rising Prevalence

The global acoustic neuroma market is growing pervasively, mainly due to the rising prevalence of the condition. There are several proven, effective therapeutics and devices to treat acoustic neuroma are available in the market, which is a major factor driving the growth of the market. Indeed, technological advancements transpired in medical science and biotechnology is a key driving force behind the growth of the market, improving the outlook for the treatments.

According to a leading research firm - Market Research Future (MRFR), the global acoustic neuroma market size is expected to garner massive accruals by 2023. In its recently published analysis, MRFR also asserts that the market would register a CAGR of approximately 7.6% throughout the forecast period (2017-2023). Improving economic conditions are playing a pivotal role in the growth of the market, increasing the purchasing power of people, and access to quality healthcare.

Factors such as increasing per capita health care expenditures, governmental initiatives, spreading awareness towards the availability of novel treatment procedures to manage the condition are substantiating the growth of the market. Rising demand for new techniques for the diagnosis and advancements in surgical procedures fuel the growth of the market.

Conversely, the high cost associated with the treatment & devices, alongside, the long approval time for the clinical trials are obstructing the growth of the market. Nevertheless, factors such as the large unmet needs especially in the developing regions would support the market growth over the assessment period, providing ample scope to the market to evolve further and prompting substantial investments for R&D to bring more novelty and betterments in the imaging techniques.

Global Acoustic Neuroma Market – Segments

The report is segmented into six market dynamics to widen the scope of understanding,

By Type : Unilateral Vestibular Schwannomas and Bilateral Vestibular Schwannomas.

By Diagnosis : Hearing Test (audiometry), Electronystagmography, and Magnetic Resonance Imaging (MRI), among others.

By Treatment : Monitoring, Surgery, Radiation Therapy, and Supportive Therapy, among others.

By Drug Class : Anticonvulsants, Corticosteroids, Osmotic Diuretics, and Pain Killers, among others.

By End-user : Hospitals, Diagnostic Centers, and Academic & Research Institutes, among others.

By Regions : Europe, North America, Asia Pacific, and the Rest-of-the-World.

Global Acoustic Neuroma Market – Geographical Analysis

North America dominates the global acoustic neuroma market with the largest market share. The presence of large numbers of notable players and diagnostic centers alongside, greater governmental emphasis on disease prevention & wellness foster the regional market growth. Moreover, substantial investments in R&D activities to develop novel therapies and breakthrough medicines drive the growth of the regional market.

Healthcare facilities in the US are gradually moving from treatments to wellness; as a result, the prevention and early detection of the disease become crucial. The US acoustic neuroma market, heading with the increasing diagnosed cases accounts for the largest share in the regional market. The rising prevalence of acoustic neuroma lifestyle fosters the market growth in the region.

The acoustic neuroma market in the European region is another lucrative market. Increasing numbers of cases alongside, the proliferation of advanced treatment facilities and availability of skilled medical professionals drive the market in the region. Moreover, the increasing government support for research & development, technological advancements, and well-spread awareness among people towards the availability of treatments for the condition support the regional market growth.

The Asia Pacific acoustic neuroma market is emerging as a rapidly growing market, globally. Factors substantiating the growth of the regional market include the increasing prevalence of acoustic neuroma, spreading awareness among people about the conditions, and the availability of new treatments to manage the condition. Growing markets in China and India contribute to the regional market growth majorly.

Global Acoustic Neuroma Market – Competitive Landscape

Fiercely competitive, the acoustic neuroma market appears to be fragmented due to the presence of many well-established players. These players, along with small players and new entrants, form a competitive edge in the market. To gain a competitive advantage in the market, these players incorporating strategic initiatives such as mergers & acquisitions, collaboration, expansion, and product/technology launch. Substantial investments are transpired in R&D to bring innovations in the therapy and clinical trials.

Major Players:

Players leading the global acoustic neuroma market include Siemens Healthcare (US), GE Healthcare (US), Philips Healthcare (US), Toshiba Medical Systems Corporation (Japan), Shimadzu Corporation (Japan), F. Hoffmann-La Roche AG (Switzerland), Novartis AG (Switzerland), Merck & Co., Inc. (US), and Pfizer Inc. (US), among others.

Industry/ Innovation/Related News:

July 22, 2019 ----- Med-El Corporation (the US), a leading global medical device company specializing in the development and manufacturing of implantable hearing solutions and speech processors announced receiving of the US FDA approval for its Cochlear Implants for single-sided deafness (SSD) and asymmetric hearing loss (AHL). Cochlear implants from MED-EL are the world’s most innovative devices helping children and adults with hearing loss hear life again. This is the first time ever that cochlear implants have been approved for these indications in the United States.

Contraindications for SSD and AHL are the same as for individuals receiving cochlear implants who have bilateral hearing loss, if the individual is known to be intolerant of the materials used in the implant and if an individual has an acoustic neuroma, and others.

Browse more Medical Devices Reports @ https://www.marketresearchfuture.com/categories/medical-devices-market-report

About US:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Global Augmented Bone Graft Market Production, Capacity, Revenue, Price, Gross Margin Analysis and forecast 2019-2025

Overview:

Bone grafting is known as a surgical procedure that is known for its effective handling of replacing missing bone or to repair bone fracture. The process requires extremely complex handling of the technology and this poses threat to the patient. However, recent advantages in provided by various technologies are expected to deliver the augmented bone graft market a possible CAGR of 7.8% during the forecast period of 2017 to 2023. Market Research Future (MRFR) declares that the market can get traction from various aspects like the hike in better technological integration, significant changes in the market due to better financial investment, better R&D facilities and others. Also, the inclusion of polymers and ceramics can improve the market scenario. However, high investment associated with the entire procedure can hold back the market. Ethical issues can also hold back the expected augmented bone graft market trends.

Segmentation:

The study of the market for Augmented Bone Graft can be segmented into products, application, and end-users. Such a detailed analysis of the segmentation would unfurl various factors that can impact the global market in the coming years. These factors can be assessed further on the basis of figures fetched by various adept analysts.

By product, the market for Augmented Bone Graft includes Bone Grafts Substitutes, Allografts, and Cell-based Matrices. The Allografts segment contains Machined Allografts and Demineralized Bone Matrix. The Bone Grafts Substitutes covers Bone Morphogenic Proteins (BMP) and Synthetic Bone Grafts.

By application, the market for Augmented Bone Graft includes Dental, Craniomaxillofacial, Joint Reconstruction, Long Bone, Foot & Ankle, and Spinal Fusion,

By end-user, the market for Augmented Bone Graft forms around clinics, hospitals, ambulatory surgical centers, and others. the procedure is quite complex owing to which hospitals may find better growth traction.

Regional Analysis:

North America has the better market coverage owing to high inclusion of various strategic moves and high integration of infrastructural changes. Countries in the region perform better due to their high expenditure capacity and better healthcare setup. This is working mostly for countries like the US and Canada. Other countries from the regions are receiving substantial grants to impact the global market. Various countries are also implementing favorable laws to help the market grow. Europe is getting better traction due to high healthcare spending in Germany. Orthopedic biologics is expected make substantial contribution in Europe. Healthcare spending in the Western Europe is quite substantial owing to which the market flow would be better.

In Asia Pacific region, various countries are investing substantially in the market. Governments from this region are putting in various efforts to make sure that the regional market grows at a faster speed. This gets backed up substantially by countries like India and China.

In the Middle East & Africa, the market is expected to make a sluggish growth. The Middle East market sees hike in various research and development projects. Africa, on the other hand, has several countries who are poor economies where the growth would be not that great.

Competitive Landscape:

The global market for augmented bone graft has become quite competitive owing to the inclusion of several new entrants in an already well-structured market thriving with various established players. MRFR profiled these companies for a better understanding of the global market. This profiling allows easy access to the latest moves initiated by these market players. These companies are BioMimetic Therapeutics LLC, Zimmer Holdings, Inc., Stryker Corporation, Wright Medical Technology, Inc., RTI Surgical, Inc., Smith & Nephew Plc, NuVasive, Inc., Olympus Biotech Corporation, Medtronic, Inc., NovaBone Products LLC, Integra LifeSciences Holdings Corporation, LifeNet Health, Inc., Synthes Inc., Exactech, Inc., DePuy Spine, Inc., Biomet, Inc., DePuy Synthes Companies, and AlloSource.

In June 2019, researchers from the Marshall University revealed that they are working hard on a project to understand how they can reconstruct anterior cruciate ligament (ACL) by using bone marrow concentrate, amnion, and suture tape.

Browse More Medical Devices Reports @ https://www.marketresearchfuture.com/categories/medical-devices-market-report

About US:

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Healthcare Revenue Cycle Management Market Research Report 2019 Analysis and Forecast to 2027

The healthcare revenue cycle management (HRCM) market growth leaps and bounds. Considerable advancements in healthcare IT and the proliferating medical sector drive the market growth, predominantly. The aggressively increasing population years by years is prompting the demand for the highest quality, coordinated care. Besides, rising administrative & operational expenses required to keep the show running in healthcare set-ups are demanding cost-effective alternatives.

The pressure to curtail these expenses in healthcare organizations is increasing continually. As a commutative result of these, the adoption of healthcare RCM solutions has increased dramatically, over the recent years and so is rising the healthcare RCM market. According to Market Research Future (MRFR), the global healthcare revenue cycle management market is expected to generate a valuation of USD 175,163.5 MN by 2024.

In its recently published study, MRFR also asserts that the market would register over 12 % CAGR throughout the assessment period (2017-2024). The emergence of automated revenue cycle management is a major driving force behind the enormous growth of healthcare RCM market. The viable solutions offered by RCM are widening its uptake across the globe.

With the increasing accuracy & efficiency and access to healthcare IT systems, RCM solution further allows increased revenue generation, which acts as a tailwind pushing up the market growth. Additional factors such as the rapidly developing healthcare infrastructures, growing digitization, and the augmenting demand for data integration, data quality, management, and data governance substantiate market growth.

Strong clinical network connectivity with medical practitioners is the latest trend observed in the market, which is projected to continue throughout the review period fostering the market growth.

Global HRCM Market - Segments

The report is segmented into five market dynamics to widen the scope of understanding,

By Deployment : On-cloud, On-premises, and Web-based, others.

By Component : Software and Service, among others.

By Product Type : Standalone and Integrated, among others

By End-users : Hospitals and Ambulatory Services, among others.

By Regions : Asia Pacific, Europe, North America, and Rest-of-the-World.

Global Healthcare RCM Market - Geographical Analysis

North America leads the global HRCM market with the largest market share. High per capita healthcare expenditures and well-established healthcare sectors in the region drive the growth of the regional market. Moreover, the rapid adoption of RCM solutions in increasing numbers of healthcare set-ups impacts the market growth in the region, positively.

Favorable government policies and enhanced incentives foster the growth of the regional market. Canada and the US account for the key contributors to the regional market growth due to the successful implementations of IT solutions in their healthcare systems. The presence of well-developed healthcare infrastructures and IT sector and regulatory framework would further boost the market growth in the region.

Europe takes the second lead in the global healthcare RCM market. Factors such as the rapid technological advancements in well-developed healthcare sectors in the region substantiate the regional market growth. Additionally, increased digitization and increasing focus on data integration, data quality, management, and data governance drive the growth in the regional market, predominantly.

The Asia Pacific healthcare revenue cycle management market is growing briskly. Rapid technological advancements and the increasing adoption of RCM tools in healthcare facilities is leading the growth of the regional market. APAC countries such as Japan, China, and India account for the major contributors to the regional market growth due to the wide adoption of HRCM products and services.

Global Healthcare RCM Market - Competitive Landscape

The highly competitive Healthcare RCM market appears fragmented due to the several large and small key players along with the new entrants forming a competitive landscape. Key players through strategic partnership, acquisition, expansion, collaboration, product & technology launch try to gain competitive advantage. They make substantial investments in R&D to develop a technology that is unrivaled and is entirely on a different level compared to their competition.

Major Players:

Players leading the global HRCM market include Epic Systems (US), General Electric Company (US), Cerner Corporation (US), Quest Diagnostics (US), McKesson Corporation (US), Allscripts (US), and Siemens Healthcare (Germany) among others.

Industry/Innovation/Related News:

September 23, 2019 --- Cerner Corporation (the US), a leading global provider of health information technology solutions, services, devices, and hardware announced its partnership with Simplee (the US), a software-as-a-service company that develops payment software for the health care industry.

The aim is to help improve patient experience through a more consumer-centric experience that lets care recipients better understand the billing process. The partnership would enable Cerner to add Simplee's financial engagement platform to its revenue cycle portfolio and incorporate its billing tools into its consumer-facing technology.

September 19, 2019 --- Zotec Partners LLC (the US), one of the largest revenue cycle management (RCM) providers announced that it has been selected to Transform the healthcare financial experience in the recently launched Walmart Health Center, a largest in-store clinic in Dallas (the US). Zotec with its end-to-end RCM technology and services, would simplify its healthcare processes and provide its customers with more access & control over their healthcare experiences, including primary care, dental, vision, and mental health services.

Browse More Healthcare IT Reports @ https://www.marketresearchfuture.com/categories/healthcare-it-market-report

About US:

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Surgical Equipment Market Revenue, Opportunity, Forecast and Value Chain Analysis 2019

The global surgical equipment market share is poised to grow significantly and strike a CAGR of 6.2% over the forecast period of 2017-2023, asserts Market Research Future (MRFR) in an extensive study. The growth of the global surgical equipment market is stemmed from the massive rise in the volume of surgeries across the globe. Rise in the number of cardiovascular, orthopedic, ophthalmic, and neurosurgeries have generated greater demand for surgical equipment such as electrosurgical devices, surgical sutures and staples, handheld instruments, electrosurgical generators, and monitoring devices which stimulates the growth of the market. The use of advanced surgical equipment is essential for the success rate of surgeries. In addition, the surging prevalence of chronic diseases on a global scale has been a plus for the market growth. Innovation in design, material, and quality which can ensure longer lifecycle is also expected to boost the growth of the market. Other factors contributing to the growth of the market include the mounting number in the establishment of medical facilities in diverse geographies such as hospitals, clinics, ambulatory surgical centers, and others. On the flip side, the growth of the global surgical equipment market might be hindered by hefty costs of surgical equipment and stringent regulatory norms monitoring surgical equipment industry.
Segmentation
The global surgical equipment market has been segmented based on product type, application, and end-user.
By product type, the market global surgical equipment market has been segmented into surgical sutures and staplers, handheld instruments, electrosurgical devices, electrosurgical generators, monitoring devices, and others. The Surgical sutures and staplers segment has been further segmented into absorbable and non-absorbable sutures. The handheld instruments segment has been further segmented into forceps, sutures, visual scope, and others. The electrosurgical devices segment has been further segmented into electrosurgical instruments such as HET bipolar system, electrosurgical pencils, smoke evacuation system, electrosurgical generators, and others.
By application, the global surgical equipment market has been segmented into wound closure, neurosurgery, cardiovascular surgeries, urology, orthopedic surgery, and others.
By end-user, the global surgical equipment market is segmented into hospitals, ambulatory surgical centers, and others.
Regional Analysis
The Americas, Asia Pacific (APAC), Europe, and the Middle East & Africa (MEA) are the key markets for surgical equipment.
The Americas is at the forefront of the global surgical equipment market owing to the rapid expansion of the medical device industry in the region. The growing focus on quality care and the availability of technologically-advanced surgical devices also favor market growth. In addition, the presence of various key medical device manufacturers in the region and increasing volume of surgeries augments the growth of the market. Other boosting a factor include high healthcare expenditure and the rise in the prevalence of chronic diseases.
Europe too is a significant market driven by the growing presence of key medical device manufacturers in the region. High government support and favorable medical device policies support the growth of the market. Expanding healthcare spending in the developed economies of the region such as the UK and Germany are likely to foster the growth of the market.
APAC market is poised to showcase rapid growth over the forecast period driven by the ever-increasing prevalence of chronic diseases in the region and subsequent rise in surgeries. High healthcare expenditure in the developing economies of the region such as China, Japan, Australia and India are likely to catapult the growth of the market on an upward trajectory. Availability of skilled healthcare professionals also acts as a plus for the growth of the market.
The MEA market is spurred by increasing healthcare expenditure in the Gulf nations and growing demand for primary care services in the Africa region.
Competitive Landscape
The eminent players in the global surgical equipment market include Synergetics USA, Inc. (US), KLS Martin (Germany), Erbe Elektromedizin GmbH (Germany), B. Braun Melsungen AG (Germany), KARL STORZ & Co. (US), Smith & Nephew (UK), Ethicon US, LLC. (US), Stryker Corporation (US), CONMED Corporation (US), MEDICON (US), Integra LifeSciences Corporation (US), and COVIDIEN (US).
Industry Updates
November 2018- BandGrip, a company focused on innovation of wound closure devices, introduced the Micro-Anchor Skin Closures, a wound closure device for better healing results. The new device is based on micro anchor technology which facilitates better grip compared to traditional wound closure devices.
Browse More Medical Devices Reports @ https://www.marketresearchfuture.com/categories/medical-devices-market-report
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com